TREA

86357017 - NCOUNTER SPRINT

Follow

Information

  • Trademark
  • 86357017
  • Serial Number
    86357017
  • Registration Number
    5124745
  • Filing Date
    August 04, 2014
    10 years ago
  • Registration Date
    January 17, 2017
    8 years ago
  • Transaction Date
    July 05, 2024
    6 months ago
  • Status Date
    June 29, 2022
    2 years ago
  • Published for Opposition Date
    September 22, 2015
    9 years ago
  • Location Date
    June 29, 2022
    2 years ago
  • First Use Anywhere Date
    September 01, 2015
    9 years ago
  • First Use In Commerce Date
    September 01, 2015
    9 years ago
  • Status Code
    702
  • Current Location
    TMEG LAW OFFICE 102
    Employee Name
    REEVES, APRIL ELIZABET
  • Attorney Docket Number
    31353-TM1022
    Attorney Name
    Alyssa M. Worsham
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
NCOUNTER SPRINT
Case File Statements
  • GS0091: computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples, detecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications, all being downloadable
  • GS0051: diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care, namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
  • PM0001: ENCOUNTER SPRINT
  • GS0011: diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors, namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing
Case File Event Statements
  • 11/24/2014 - 10 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/7/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/13/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/14/2014 - 10 years ago
    3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK
  • 11/17/2014 - 10 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/24/2014 - 10 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/24/2014 - 10 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/29/2015 - 9 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/12/2015 - 9 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 6/22/2015 - 9 years ago
    8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 6/22/2015 - 9 years ago
    9 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 7/10/2015 - 9 years ago
    10 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 7/10/2015 - 9 years ago
    11 - PETITION TO REVIVE-GRANTED Type: PETG
  • 7/10/2015 - 9 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/10/2015 - 9 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/11/2015 - 9 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/12/2015 - 9 years ago
    15 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 6/9/2016 - 8 years ago
    26 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 8/19/2015 - 9 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 9/2/2015 - 9 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/22/2015 - 9 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/22/2015 - 9 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/17/2015 - 9 years ago
    22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/13/2016 - 8 years ago
    23 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/13/2016 - 8 years ago
    25 - SOU EXTENSION 1 FILED Type: EXT1
  • 6/9/2016 - 8 years ago
    24 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/13/2016 - 8 years ago
    36 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 6/10/2016 - 8 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/7/2016 - 8 years ago
    28 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 11/7/2016 - 8 years ago
    29 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/7/2016 - 8 years ago
    30 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/7/2016 - 8 years ago
    32 - USE AMENDMENT FILED Type: IUAF
  • 11/17/2016 - 8 years ago
    31 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 11/17/2016 - 8 years ago
    33 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 11/18/2016 - 8 years ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/12/2016 - 8 years ago
    35 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 3/18/2020 - 4 years ago
    38 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 6/29/2022 - 2 years ago
    41 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/29/2022 - 2 years ago
    42 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A
  • 1/17/2017 - 8 years ago
    37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/17/2022 - 3 years ago
    39 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 1/25/2022 - 2 years ago
    40 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 7/4/2024 - 6 months ago
    44 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 6/29/2022 - 2 years ago
    43 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85